Self-made lovastatin/nicotinic acid sustained-release tablets and its pharmacokinetics in healthy volunteers

FAN Xin-hua,TU Yong-rui,HU Yi-qiao

2009-01-01

Abstract:Objective To prepare lovastatin/nicotinic acid sustained-release tablets in accordance with Advicor~(?) developed by Kos Pharmaceuticals.Methods The product was prepared by formula screening and bilayer tabletting and then the research on in vitro release and pharmacokinetics in healthy volunteers were undertaken.Results Results of in vitro release:30min dissolution for lovastatin is not less than 80%,2h,4h and 8h release amount for nicotinic acid is 30%,50%and 80%respectively.The f2 value is more than 50.Primary results ofpharmacokinetics in healthy volunteers: T_(max)、C_(max) and t_(1/2) in lovastatin single group(take food) were(1.75±0.42) h、(2.12±0.67) ng/mL and(11.21±7.60) h respectively,and T_(max)、C_(max) and t_(1/2) in lovastatin single group(empty) were(1.90±0.74) h、(l.49±0.60)ng/mL and (12.24±7.65) h respectively;T_(max)、C_(max) and t_(1/2) in nicotinic acid single group(take food) were(3.17±1.05)h、(317.3±407.1) ng/mL and(10.39±5.26)h respectively,and T_(max)、C_(max) and t_(1/2) in nicotinic acid single group(empty) were(1.63±0.48) h、(247.3±312.9) ng/mL and(11.54±5.01 ) h.Conclusion The curve of in vitro release of our product is the same as Advicor~(?).Lovastatin is characterized as rapid releasing and nicotinic acid is characterized as sustained releasing.